Marietta Investment Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.56M | Sell |
3,866
-127
| -3% | -$129K | 0.71% | 44 |
|
|
2025
Q4 | $4.29M | Sell |
3,993
-709
| -15% | -$678K | 0.85% | 34 |
|
|
2025
Q3 | $3.59M | Buy |
4,702
+118
| +3% | +$87.8K | 0.69% | 43 |
|
|
2025
Q2 | $3.57M | Sell |
4,584
-180
| -4% | -$140K | 0.78% | 36 |
|
|
2025
Q1 | $3.93M | Sell |
4,764
-540
| -10% | -$449K | 0.95% | 31 |
|
|
2024
Q4 | $4.09M | Sell |
5,304
-2,635
| -33% | -$2.18M | 0.9% | 34 |
|
|
2024
Q3 | $7.03M | Sell |
7,939
-207
| -3% | -$186K | 1.49% | 19 |
|
|
2024
Q2 | $7.38M | Buy |
8,146
+3,437
| +73% | +$2.75M | 1.62% | 17 |
|
|
2024
Q1 | $3.66M | Buy |
4,709
+742
| +19% | +$528K | 0.8% | 41 |
|
|
2023
Q4 | $2.31M | Buy |
3,967
+57
| +1% | +$33.3K | 0.58% | 49 |
|
|
2023
Q3 | $2.1M | Hold |
3,910
| – | – | 0.59% | 45 |
|
|
2023
Q2 | $1.83M | Hold |
3,910
| – | – | 0.48% | 53 |
|
|
2023
Q1 | $1.34M | Hold |
3,910
| – | – | 0.37% | 55 |
|
|
2022
Q4 | $1.43M | Hold |
3,910
| – | – | 0.4% | 52 |
|
|
2022
Q3 | $1.4M | Hold |
3,910
| – | – | 0.41% | 52 |
|
|
2022
Q2 | $1.27M | Hold |
3,910
| – | – | 0.38% | 59 |
|
|
2022
Q1 | $1.12M | Hold |
3,910
| – | – | 0.26% | 79 |
|
|
2021
Q4 | $1.08M | Buy |
3,910
+100
| +3% | +$25.4K | 0.23% | 88 |
|
|
2021
Q3 | $880K | Hold |
3,810
| – | – | 0.2% | 95 |
|
|
2021
Q2 | $874K | Hold |
3,810
| – | – | 0.2% | 94 |
|
|
2021
Q1 | $712K | Sell |
3,810
-990
| -21% | -$194K | 0.18% | 94 |
|
|
2020
Q4 | $810K | Hold |
4,800
| – | – | 0.21% | 85 |
|
|
2020
Q3 | $710K | Hold |
4,800
| – | – | 0.21% | 83 |
|
|
2020
Q2 | $788K | Hold |
4,800
| – | – | 0.26% | 66 |
|
|
2020
Q1 | $666K | Sell |
4,800
-421
| -8% | -$57.8K | 0.29% | 67 |
|
|
2019
Q4 | $686K | Sell |
5,221
-7,950
| -60% | -$922K | 0.22% | 81 |
|
|
2019
Q3 | $1.47M | Sell |
13,171
-2,300
| -15% | -$256K | 0.51% | 52 |
|
|
2019
Q2 | $1.71M | Sell |
15,471
-100
| -0.6% | -$11.8K | 0.56% | 47 |
|
|
2019
Q1 | $2.02M | Hold |
15,571
| – | – | 0.64% | 48 |
|
|
2018
Q4 | $1.8M | Buy |
15,571
+9,721
| +166% | +$1.09M | 0.69% | 45 |
|
|
2018
Q3 | $628K | Buy |
+5,850
| New | +$585K | 0.19% | 85 |
|
|
2016
Q4 | – | Sell |
-4,135
| Closed | -$332K | – | 146 |
|
|
2016
Q3 | $332K | Buy |
4,135
+110
| +3% | +$8.8K | 0.11% | 117 |
|
|
2016
Q2 | $317K | Buy |
4,025
+325
| +9% | +$24.5K | 0.11% | 120 |
|
|
2016
Q1 | $266K | Hold |
3,700
| – | – | 0.11% | 111 |
|
|
2015
Q4 | $312K | Hold |
3,700
| – | – | 0.13% | 104 |
|
|
2015
Q3 | $298K | Hold |
3,700
| – | – | 0.12% | 105 |
|
|
2015
Q2 | $309K | Buy |
+3,700
| New | +$282K | 0.12% | 101 |
|
Other funds holding LLY
VCM
VPM
Marietta Investment Partners's LLY Position: Q1 2026 in Review
Marietta Investment Partners reduced its Eli Lilly (LLY) stake by 3.2% in Q1 2026, selling an estimated $129K and leaving 3,866 shares worth $3.56M. The position accounts for 0.71% of the portfolio, ranked #44.
Marietta Investment Partners first reported a position in LLY in Q2 2015 and has held it in 37 quarters since. The position peaked at $7.38M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Marietta Investment Partners held 3,866 shares of Eli Lilly worth $3.56M as of Q1 2026.
- Marietta Investment Partners sold 127 Eli Lilly shares in Q1 2026, an estimated $129K.
- Eli Lilly made up 0.71% of Marietta Investment Partners's portfolio in Q1 2026, its #44 holding.
- Marietta Investment Partners first reported a position in Eli Lilly in Q2 2015 and has held it in 37 quarters since.
- Marietta Investment Partners's Eli Lilly position peaked at $7.38M in Q2 2024.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Marietta Investment Partners's 13F filing for Q1 2026, filed 28 Apr 2026.